Overall, among the aforementioned miRs, miR-27a is suggested to be the most putative therapeutic target as it can regulate three of the 4 important photogenic genes in FH patients including LDLR, PCSK9, and LDLRAP1. This evidence concerns the gene LDLRAP1 and familial hyperaldosteronism.